|
|
Volumn 35, Issue 5, 2000, Pages 449-455
|
|
Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols
a
|
|
Author keywords
Acute neurotoxicity; B lineage acute lymphoblastic leukemia; Childhood; Intermediate risk protocols
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTILEUKEMIC AGENT;
ASPARAGINASE;
ASPARAGINASE MEDAC;
CORTICOSTEROID;
CYTARABINE;
DAUNORUBICIN;
FOLINIC ACID;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
UNCLASSIFIED DRUG;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
AGE;
ARTICLE;
B CELL LEUKEMIA;
BRAIN INFECTION;
BRAIN LEUKEMIA;
BRAIN PROTECTION;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ELECTROENCEPHALOGRAM;
FEMALE;
FOLLOW UP;
HUMAN;
INFANT;
INTERMETHOD COMPARISON;
LUMBAR PUNCTURE;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
NEUROTOXICITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SCHOOL CHILD;
SKULL IRRADIATION;
SURVIVAL TIME;
SYMPTOM;
TREATMENT OUTCOME;
ADOLESCENT;
ANTI-INFLAMMATORY AGENTS;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CENTRAL NERVOUS SYSTEM DISEASES;
CHILD;
CHILD, PRESCHOOL;
COMBINED MODALITY THERAPY;
CYTARABINE;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
HYDROCORTISONE;
INCIDENCE;
INFANT;
INJECTIONS, SPINAL;
ITALY;
LEUKEMIA, B-CELL, ACUTE;
MALE;
METHOTREXATE;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
|
|
EID: 0033769187
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/1096-911X(20001101)35:5<449::AID-MPO2>3.0.CO;2-X Document Type: Article |
|
Times cited : (46)
|
|
References (37)
|
